LIBERTY TRIPADVISOR HDG-A (LTRPA)

US5314651028 - Common Stock

0.26  -0.07 (-20.83%)

After market: 0.25 -0.01 (-3.85%)

Fundamental Rating

2

Taking everything into account, LTRPA scores 2 out of 10 in our fundamental rating. LTRPA was compared to 68 industry peers in the Interactive Media & Services industry. LTRPA may be in some trouble as it scores bad on both profitability and health. LTRPA is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

In the past year LTRPA has reported negative net income.
LTRPA had a positive operating cash flow in the past year.
LTRPA had negative earnings in 4 of the past 5 years.
Of the past 5 years LTRPA 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of LTRPA (-0.65%) is better than 64.18% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.52%, LTRPA is in the better half of the industry, outperforming 67.16% of the companies in the same industry.
Industry RankSector Rank
ROA -0.65%
ROE N/A
ROIC 1.52%
ROA(3y)-4.4%
ROA(5y)-2.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 4.53%, LTRPA is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
In the last couple of years the Operating Margin of LTRPA has grown nicely.
The Profit Margin and Gross Margin are not available for LTRPA so they could not be analyzed.
Industry RankSector Rank
OM 4.53%
PM (TTM) N/A
GM N/A
OM growth 3Y-10.65%
OM growth 5Y72.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

LTRPA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LTRPA has been increased compared to 1 year ago.
LTRPA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LTRPA has been reduced compared to a year ago.

2.2 Solvency

LTRPA has an Altman-Z score of 0.43. This is a bad value and indicates that LTRPA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.43, LTRPA is doing worse than 64.18% of the companies in the same industry.
LTRPA has a debt to FCF ratio of 6.02. This is a slightly negative value and a sign of low solvency as LTRPA would need 6.02 years to pay back of all of its debts.
LTRPA has a Debt to FCF ratio of 6.02. This is in the better half of the industry: LTRPA outperforms 67.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.02
Altman-Z 0.43
ROIC/WACC0.52
WACC2.92%

2.3 Liquidity

A Current Ratio of 1.77 indicates that LTRPA should not have too much problems paying its short term obligations.
LTRPA has a Current ratio (1.77) which is in line with its industry peers.
LTRPA has a Quick Ratio of 1.77. This is a normal value and indicates that LTRPA is financially healthy and should not expect problems in meeting its short term obligations.
LTRPA's Quick ratio of 1.77 is in line compared to the rest of the industry. LTRPA outperforms 41.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77

1

3. Growth

3.1 Past

LTRPA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -120.36%.
Looking at the last year, LTRPA shows a very strong growth in Revenue. The Revenue has grown by 37.20%.
LTRPA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.00% yearly.
EPS 1Y (TTM)-120.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-85.27%
Revenue 1Y (TTM)37.2%
Revenue growth 3Y-1.47%
Revenue growth 5Y-1%
Revenue growth Q2Q18.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LTRPA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

LTRPA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LTRPA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.1
EV/EBITDA -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LTRPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY TRIPADVISOR HDG-A

NASDAQ:LTRPA (10/27/2023, 7:28:06 PM)

After market: 0.25 -0.01 (-3.85%)

0.26

-0.07 (-20.83%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.91M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.65%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 4.53%
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-120.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.2%
Revenue growth 3Y-1.47%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y